Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Clostridioides difficile infection (CDI) causes significant morbidity and mortality; however, the diagnosis of CDI remains controversial. The primary aim of our study was to evaluate the association of polymerase chain reaction (PCR) cycle threshold (Ct) values with CDI disease severity, recurrence, and mortality among adult patients with CDI.

Design: Retrospective cohort study.

Setting: Single tertiary-care hospital.

Patients: Adult patients diagnosed with hospital-onset, healthcare facility-associated CDI from June 2014 to September 2015.

Methods: We performed a retrospective chart review of included patients. Univariate and multivariable logistic regression methods were used to evaluate the association between Ct values and CDI severity, 8-week recurrence, and 30-day mortality.

Results: Among 318 included patients, 51% were male and the mean age was 62 years; ~32% of the patients developed severe CDI and 11% developed severe-complicated CDI. The 30-day all-cause mortality rate was 11% and the 8-week recurrence rate was 9.5%. The overall mean Ct value was 32.9 (range, 23-40). Multivariable analyses showed that lower values of PCR Ct were associated with increased odds of 30-day morality (odds ratio [OR] 0.83; 95% confidence interval [CI], 0.72-0.96) but were not independently associated with CDI severity (OR, 0.99; 95% CI, 0.90-1.09) or recurrence (OR, 0.88; 95% CI, 0.77-1.00).

Conclusions: Our findings suggest that PCR Ct values at the time of diagnosis may have a limited predictive value and utility in clinical decision making for inpatients with CDI. Larger, prospective studies across different patient populations are needed to confirm our findings.

Download full-text PDF

Source
http://dx.doi.org/10.1017/ice.2020.1405DOI Listing

Publication Analysis

Top Keywords

cdi
9
polymerase chain
8
chain reaction
8
reaction pcr
8
pcr cycle
8
cycle threshold
8
evaluate association
8
values cdi
8
adult patients
8
included patients
8

Similar Publications

infection and antibiotic prescribing at a regional hospital in Australia: a case-control study.

Antimicrob Steward Healthc Epidemiol

September 2025

National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT, Australia.

Background: infections (CDI) increased at a large, regional hospital in New South Wales, Australia, in 2021, coinciding with an increase at hospitals Australia wide. We aimed to investigate the association between antibiotic prescribing practices and hospital-acquired CDI at the hospital to inform antimicrobial stewardship (AMS) programs.

Methods: We conducted a retrospective case-control study for the period July 1, 2018, and June 30, 2022.

View Article and Find Full Text PDF

Bacterial volatile organic compounds (VOCs) have been investigated as non-invasive approaches for the diagnosis of infectious diseases. Here, we aimed to explore potential diagnostic markers by profiling VOCs in cultures of unique clinical Clostridioides difficile (C. difficile) isolates and stool samples from pediatric patients with C.

View Article and Find Full Text PDF

Overview: We analysed Australian Immunisation Register (AIR) data, predominantly for National Immunisation Program funded vaccines, as at 2 April 2023 for children, adolescents and adults, focusing on the calendar year 2022 and on trends from previous years. This report aims to provide comprehensive analysis and interpretation of vaccination coverage data to inform immunisation policy and programs.

Children: Fully vaccinated coverage in Australian children in 2022 was 0.

View Article and Find Full Text PDF

Shigellosis in South East Metropolitan Melbourne, 1 January 2022 - 31 March 2023.

Commun Dis Intell (2018)

February 2025

Faculty of Medicine, Nursing and Health Science, Monash University, Victoria; South East Public Health Unit, Monash Health, Victoria.

Introduction: Shigella is a notifiable condition in Victoria under the Public Health and Wellbeing Act. Since 24 October 2022, the South East Public Health Unit (SEPHU) has been managing these notifications for the south east region of Melbourne.

Aim: This study aimed to determine the demographics and risk factors for acquisition of shigellosis cases in the SEPHU catchment.

View Article and Find Full Text PDF

Australian Gonococcal Surveillance Program, 1 January to 31 March 2025.

Commun Dis Intell (2018)

February 2025

The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW 2031, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW 2052, Au

The National Neisseria Network (NNN), Australia, established in 1979, comprises reference laboratories in each state and territory. Since 1981, the NNN has reported data for the Australian Gonococcal Surveillance Programme (AGSP), on antimicrobial susceptibility profiles for Neisseria gonorrhoeae isolated from each jurisdiction for an agreed group of agents. The antibiotics reported represent current or potential agents used for the treatment of gonorrhoea, and include ceftriaxone, azithromycin, ciprofloxacin and penicillin.

View Article and Find Full Text PDF